Aktar Mert
Transaction: 05/27/2026
BUY
Change
+20,582
Price
$8.59
Filing
05/29/2026
Type
BUY
Kyverna Therapeutics, Inc.
KYTX • Biotechnology
$8.25
▼ -0.10 (-1.20%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$491.23M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 24.2%Manageable debt level · 0.12Healthy liquidity · 7.75Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:54 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$8.25
Change-1.20%
Market Cap$491.23M
52W Range3.27 - 13.67
Beta1.94
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.12
Current Ratio7.75
Quick Ratio7.75
Revenue 5Y-100.00%
Price$8.25
Change-1.20%
Market Cap$491.23M
52W Range3.27 - 13.67
Beta1.94
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.12
Current Ratio7.75
Quick Ratio7.75
Revenue 5Y-100.00%
Target$25.00
Target Upside203.03%
Target Median$25.00
Target Range25.00 - 25.00
Volume723.89K
Avg Volume1.07M
EPS Surprise0.09
Investment DNA
How strong this company looks for long-term investors
55
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score▼
Positive revenue growth · 24.2%Manageable debt level · 0.12Healthy liquidity · 7.75Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$25.00
Mean
$25.00
Median
$25.00
High
$25.00
Insider Transactions
Recent executive and insider activity
Aktar Mert
Transaction: 05/27/2026
BUY
Change
+5,093
Price
Not reported
Filing
05/29/2026
Type
BUY
Shaw Christi
Transaction: 05/27/2026
SELL
Change
-4,194
Price
$8.59
Filing
05/29/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Aktar Mert | BUY | +20,582 | $8.59 | 05/27/2026 | 05/29/2026 |
| Aktar Mert | BUY | +5,093 | Not reported | 05/27/2026 | 05/29/2026 |
| Shaw Christi | SELL | -4,194 | $8.59 | 05/27/2026 | 05/29/2026 |
| SEIDENBERG BETH C | BUY | +20,582 | $8.59 | 05/27/2026 | 05/29/2026 |
| SEIDENBERG BETH C | BUY | +5,093 | Not reported | 05/27/2026 | 05/29/2026 |
| Cohen Fred E | BUY | +20,582 | $8.59 | 05/27/2026 | 05/29/2026 |
| Cohen Fred E | BUY | +5,093 | Not reported | 05/27/2026 | 05/29/2026 |
| CLARK IAN T | BUY | +20,582 | $8.59 | 05/27/2026 | 05/29/2026 |
| CLARK IAN T | BUY | +5,093 | Not reported | 05/27/2026 | 05/29/2026 |
| Martini Gregory S. | OTHER | 0 | Not reported | 05/18/2026 | 05/20/2026 |
| Martini Gregory S. | BUY | +325,000 | $8.54 | 05/18/2026 | 05/20/2026 |
| Dac Nadia | OTHER | 0 | Not reported | 05/04/2026 | 05/06/2026 |
| Dac Nadia | BUY | +300,000 | $9.00 | 05/04/2026 | 05/06/2026 |
| GEHCHAN NAJI | BUY | +18,000 | Not reported | 03/13/2026 | 03/17/2026 |
| GEHCHAN NAJI | BUY | +105,000 | $8.95 | 03/13/2026 | 03/17/2026 |
| Biddle Warner Weston | BUY | +58,000 | Not reported | 03/13/2026 | 03/17/2026 |
| Biddle Warner Weston | BUY | +350,000 | $8.95 | 03/13/2026 | 03/17/2026 |
| GRASSO MARC | BUY | +10,000 | Not reported | 03/13/2026 | 03/17/2026 |
| GRASSO MARC | BUY | +65,000 | $8.95 | 03/13/2026 | 03/17/2026 |
| Miller Andrew Craig | BUY | +11,006 | Not reported | 02/24/2026 | 03/04/2026 |